You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft vs Host Disease

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)

Recruiting
  • Graft Vs Host Disease
  • Graft-versus-host-disease
  • CliniMacs®
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022

Transplant-Related Disorder Trial (Ruxolitinib)

Not yet recruiting
  • Transplant-Related Disorder
  • (no location specified)
Oct 25, 2022

Scleroderma, Systemic, Morphea, Graft Vs Host Disease Trial in Murray (UVA-1 Phototherapy)

Enrolling by invitation
  • Scleroderma, Systemic
  • +2 more
  • UVA-1 Phototherapy
  • Murray, Utah
    University of Utah Dermatology
Nov 1, 2022

Chronic GVHD Trial in Duarte (biological, procedure, other)

Active, not recruiting
  • Chronic Graft Versus Host Disease
  • Aldesleukin
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

Recruiting
  • Chronic Graft vs Host Disease
  • Regulatory T-cell enriched infusion
  • Sevilla, Spain
    José Antonio Pérez Simón
May 20, 2022

Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota

Not yet recruiting
  • Acute Graft Versus Host Disease
  • +3 more
  • Fecal Microbiota Transplantation Capsule
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Mapping for Detection of Chronic Lung Injury in Hematopoietic

Recruiting
  • Chronic Lung Disease
  • +2 more
    • Ann Arbor, Michigan
      The University of Michigan Cancer Center
    May 9, 2023

    Graft-versus-host Disease Trial in Beijing (SHR0302)

    Not yet recruiting
    • Graft-versus-host Disease
    • Beijing, Beijing, China
      Beijing Hospital
    May 4, 2023

    Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute

    Recruiting
    • Chronic Graft vs Host Disease
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Graft-versus-host-disease, Graft Vs Host Disease Trial in Saint Louis (Baricitinib)

    Recruiting
    • Graft-versus-host-disease
    • Graft Vs Host Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 4, 2022

    GVHD, JNS Kinase, Topical Administration Trial run by the NIAMS (Ruxolitinib 1.5% cream, vehicle cream)

    Terminated
    Has Results
    • Graft Versus Host Disease
    • +2 more
    • Ruxolitinib 1.5% cream
    • vehicle cream
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 21, 2022

    Chronic GVHD Response Measures Validation

    Active, not recruiting
    • Graft vs Host Disease
      • Seattle, Washington
        Fred Hutchinson Cancer Research Center
      Feb 28, 2022

      Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)

      Active, not recruiting
      • Graft Vs Host Disease
      • GVHD
      • Tampa, Florida
      • +1 more
      Jul 27, 2022

      Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

      Recruiting
      • Graft-versus-host-disease
      • Relapse
      • Treatment Arm - high dose ATG
      • Control Arm - standard of care
      • Calgary, Alberta, Canada
        Tom Baker Cancer Centre
      Oct 14, 2022

      Chronic GVHD Trial (Belumosudil)

      Not yet recruiting
      • Chronic Graft Versus Host Disease
      • (no location specified)
      Jan 5, 2023

      Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

      Active, not recruiting
      • Chronic Graft-versus-host-disease
      • Salt Lake City, Utah
        Huntsman Cancer Institute at University of Utah
      Jan 30, 2023

      Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)

      Recruiting
      • GVHD,Acute
      • GVHD, Chronic
      • Physical exercise
      • Salamanca, Spain
        University of Salamanca
      May 27, 2022

      Non-sclerotic Cutaneous Chronic Graft-versus-host Disease Trial in New York (topical ruxolitinib 1.5% cream, Topical

      Recruiting
      • Non-sclerotic Cutaneous Chronic Graft-versus-host Disease
      • topical ruxolitinib 1.5% cream
      • Topical vehicle/moisturizer cream
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Dec 20, 2022

      Acute Graft-versus-Host Disease

      Active, not recruiting
      • Acute Graft-versus-Host Disease
      • Allogeneic Stem Cell Transplant
      • Blood samples
      • Columbus, Ohio
        Ohio State University Medical Center
      Apr 18, 2022

      GVHD Trial in Cleveland (Allogeneic mesenchymal stromal cells (MSCs), Extracorporeal photopheresis (ECP))

      Not yet recruiting
      • Graft Versus Host Disease
      • Allogeneic mesenchymal stromal cells (MSCs)
      • Extracorporeal photopheresis (ECP)
      • Cleveland, Ohio
        University Hospitals Cleveland Medical Center, Case Comprehensiv
      Nov 14, 2022

      Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)

      Completed
      • Chronic Graft-versus-host Disease (cGVHD)
      • AMG 592
      • Placebo
      • Aventura, Florida
        Research Site
      May 16, 2023

      Improved Methods of Cell Selection for Bone Marrow Transplant

      Recruiting
      • Graft-Versus-Host Disease
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      GVHD, Acute Trial (CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs), Placebo,

      Not yet recruiting
      • Graft Versus Host Disease, Acute
      • CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs)
      • +2 more
      • (no location specified)
      Dec 6, 2022